300759SZSE

2025 Annual Report of Independent Non-Executive Director (King Fung Tsang)

Pharmaron Beijing Co., Ltd.··5 pages

✨ AI Summary

This report details the performance of Independent Non-Executive Director King Fung Tsang for 2025. It covers his attendance at meetings, professional background, and commitment to fulfilling his duties diligently and independently, safeguarding shareholder interests, particularly those of small and medium shareholders. The director confirms his independence and compliance with regulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Longfor Group Holdings Limited (Beijing) New Drug Technology Co., Ltd. 2025 Annual Report of Independent Non-Executive Director (Independent Non-Executive Director: King Fung Tsang)

To all shareholders and shareholder representatives:

As an Independent Non-Executive Director of Longfor Group Holdings Limited (Beijing) New Drug Technology Co., Ltd. (hereinafter referred to as the "Company"), during my term of office in 2025, I have strictly adhered to the "Company Law," "Corporate Governance Guidelines for Listed Companies," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange GEM Listed Company Regulation and Operation Guide No. 2," "Hong Kong Stock Exchange Limited Securities Listing Rules," and other relevant laws, regulations, normative legal documents, and the "Company Articles of Association" and "Work System for Independent Non-Executive Directors" and other company-related regulations and requirements. I have actively attended relevant company meetings, diligently reviewed all proposals, made prudent decisions, paid close attention to the company's development, and promptly understood the company's production and operation information. I have faithfully performed the duties of an independent non-executive director, diligently and conscientiously, fully leveraging the independence and professionalism of an independent non-executive director, playing a due role in the standardized, stable, and healthy development of the company, and effectively safeguarding the legitimate rights and interests of the company and all shareholders, especially small and medium shareholders. On December 18, 2025, I was approved by the shareholders' meeting to become an Independent Non-Executive Director of the third board of directors, a member of the third board's Audit Committee, a member of the third board's Remuneration and Assessment Committee, and a member of the third board's Nomination Committee. The following is a report on my performance during my term of office in 2025:

I. Basic Information of Independent Non-Executive Director

(I) Work Experience, Professional Background, and Concurrent Positions

Professor King Fung Tsang, 47 years old. Since 2019, he has served as an Associate Professor at the Faculty of Law, Chinese University of Hong Kong. From 2013 to 2019, he served as an Assistant Professor at the Faculty of Law, Chinese University of Hong Kong. From June 2011 to July 2013, he served at City University of Hong Kong. In 2011, he served at Hong Kong Stock Exchange Limited. From 2006 to 2008 and in 2010, he served at Shearman & Sterling LLP. From 2002 to 2005, he served at Linklaters. Professor Tsang obtained a Bachelor of Laws and a Postgraduate Certificate in Laws (PCLL) from The University of Hong Kong. He subsequently obtained a Master of Laws and Juris Doctor degrees from Georgetown University, and a Master of Laws and Doctor of Juridical Science degrees from Columbia University, and a Master of Laws degree from University College London.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.